Global Biologics Outsourcing Formulation Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Biologics Outsourcing Formulation Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Global Biologics Outsourcing Formulation Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Stem Cell Research and Vaccine Development are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biologics Outsourcing Formulation Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biologics Outsourcing Formulation Services key companies include AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International, GenScript, Merck, Lonza Group, Catalent, Innovent Biologics and Syngene, etc. AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International are top 3 players and held % share in total in 2022.
Biologics Outsourcing Formulation Services can be divided into Analytical Testing, Process Development, Cell Development and cGMP Manufacturing, etc. Analytical Testing is the mainstream product in the market, accounting for % share globally in 2022.
Biologics Outsourcing Formulation Services is widely used in various fields, such as Stem Cell Research, Vaccine Development, Tissue Related Products Development and Others, etc. Stem Cell Research provides greatest supports to the Biologics Outsourcing Formulation Services industry development. In 2022, global % share of Biologics Outsourcing Formulation Services went into Stem Cell Research filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biologics Outsourcing Formulation Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab
Segment by Type
Analytical Testing
Process Development
Cell Development
cGMP Manufacturing
Others
Stem Cell Research
Vaccine Development
Tissue Related Products Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biologics Outsourcing Formulation Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biologics Outsourcing Formulation Services introduction, etc. Biologics Outsourcing Formulation Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Biologics Outsourcing Formulation Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
North America, Europe and Asia Pacific are the key regions for Biologics Outsourcing Formulation Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biologics Outsourcing Formulation Services key companies include AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International, GenScript, Merck, Lonza Group, Catalent, Innovent Biologics and Syngene, etc. AtbbVie, Thermo Fisher Scientific, Boehringer Ingelheim International are top 3 players and held % share in total in 2022.
Biologics Outsourcing Formulation Services can be divided into Analytical Testing, Process Development, Cell Development and cGMP Manufacturing, etc. Analytical Testing is the mainstream product in the market, accounting for % share globally in 2022.
Biologics Outsourcing Formulation Services is widely used in various fields, such as Stem Cell Research, Vaccine Development, Tissue Related Products Development and Others, etc. Stem Cell Research provides greatest supports to the Biologics Outsourcing Formulation Services industry development. In 2022, global % share of Biologics Outsourcing Formulation Services went into Stem Cell Research filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biologics Outsourcing Formulation Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab
Segment by Type
Analytical Testing
Process Development
Cell Development
cGMP Manufacturing
Others
Segment by Application
Stem Cell Research
Vaccine Development
Tissue Related Products Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biologics Outsourcing Formulation Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biologics Outsourcing Formulation Services introduction, etc. Biologics Outsourcing Formulation Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Biologics Outsourcing Formulation Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.